These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15387267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H, Ichihashi K, Inoue K, Fujita K, Okazaki Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1176-8. PubMed ID: 16720068
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome].
    Nishijima K.
    Ryoikibetsu Shokogun Shirizu; 2003 Aug 30; (38):176-8. PubMed ID: 12876959
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Neuroleptic malignant syndrome].
    Koberstein B, Balzer K, Eikmeier G, Hager W, Goebell H.
    Dtsch Med Wochenschr; 1989 May 05; 114(18):718-21. PubMed ID: 2653767
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M, Sawayama E, Sawayama T, Miyaoka H.
    Pharmacopsychiatry; 2007 Sep 05; 40(5):201-2. PubMed ID: 17874352
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Unexpected drug-interaction].
    Tajima Y.
    Rinsho Byori; 2002 Feb 05; 50(2):133-9. PubMed ID: 11925849
    [Abstract] [Full Text] [Related]

  • 13. [Narcoleptic syndrome as a possible side effect of paroxetine].
    Alonso H, Ortí-Pareja M, Jiménez-Jiménez FJ.
    Rev Neurol; 2002 Feb 05; 39(11):1092. PubMed ID: 15597274
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome after venlafaxine.
    Nimmagadda SR, Ryan DH, Atkin SL.
    Lancet; 2000 Jan 22; 355(9200):289-90. PubMed ID: 10675082
    [Abstract] [Full Text] [Related]

  • 15. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug 22; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy.
    Pantel J, Schröder J, Eysenbach K, Mundt C.
    Pharmacopsychiatry; 1997 May 22; 30(3):109-11. PubMed ID: 9211574
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome and malignant hyperthermia.
    Wijeratne C.
    Aust N Z J Psychiatry; 1996 Dec 22; 30(6):874. PubMed ID: 9034482
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome in a girl without psychosis.
    Thacker AK, Radhakrishnan K, Maloo JC, Bohlaga NH.
    Br J Clin Pract; 1990 Oct 22; 44(10):425-7. PubMed ID: 2268530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.